“Prescription drug prices are out of control,” wrote AHA President and CEO Rick Pollack and America’s Health Insurance Plans President and CEO Marilyn Tavenner in a Dec. 31 OpEd in The Hill. “The average annual cost for one specialty medication to treat a chronic condition is now more than what most families earn in a year. Big Pharma could solve the problem by committing to more rational and sustainable pricing models. Instead, for the last year, Big Pharma has chosen to point the finger at everyone else, and their decision to engage in a blame game is a tacit admission that drug prices are, in fact, too high.” To read the full column, click here.

Related News Articles

Headline
Rosalyn Carpenter, AHA Institute for Diversity and Health Equity Leadership Council member, senior vice president and chief diversity, equity, inclusion and…
Headline
Clinicians bring all of their skill and mental acuity to treat the whole patient, but there are many factors that can derail their ability to provide patient…
Blog
Minority Mental Health Awareness Month is an opportunity to acknowledge that we live in a time when the patients and communities we serve are experiencing the…
Headline
AdventHealth’s Be a Mindleader initiative aims to help children and parents become more comfortable discussing mental health and connect families to counseling…
Headline
Access to quality mental and physical health services can be a complex challenge, but for individuals of color and people with severe or chronic mental…
Headline
The Centers for Medicare & Medicaid Services July 16 released its final guidance on the Medicare Prescription Payment Plan which will begin next year. The…